GALLSTONES IN PATIENTS WITH INHERITED HEMOLYTIC DISEASES
Keywords:
Gallstones, Cholelithiasis, Choledocholithiasis, Haemolytic diseasesAbstract
The purpose is to provide an overview on the incidence of gallstone disease in patients with various types of inherited (chronic) hemolytic diseases at risk of cholelithiasis/choledocholithiasis with particular emphasis on its pathogenesis, genetic, risk factors and management. A detailed electronic literature search to determine the source of materials for this review article was done. The reported incidences of gallstones and choledocholithiasis vary according to the different types of inherited hemolytic diseases and the ethnicity of the studied populations. To date, no review article summarises the incidences of cholelithiasis in patients with various inherited haemolytic diseases was published. Regular ultrasound examination for the presence of gallstones recommended in patients with inherited haemolytic anaemias, particularly those with additional risk factors recommended. Further studies for evaluating the reasons for the higher incidence of cholelithiasis in thalassemia major and sickle cell anemia compared to hereditary spherocytosis; the effect of co inheritance of alpha thalassaemia on decreasing bilirubin level in patients with sickle cell disease and beta thalassaemia; the effect of the co inheritance of UGT1A1 and ABCG8 gene mutation on the incidence of gallstones in other blood diseases such as Hb-H disease, autoimmune haemolytic anaemias, congenital dyserythropoietic anaemia, hereditary elliptocytosis, Southeast Asian Ovalocytosis, glucose-6-phosphate and pyruvate kinase deficiency are recommended. Evaluation of the potential role of the solubility of the mutant proteins and haemoglobin subunit in the red blood cells as an additional mechanism for the development of gallstones in patients with inherited haemolytic anaemias recommended.
Downloads
References
Poddar U. Gallstone Disease in Children. Indian Pediatr 2010;47:945-53.
Carpenter SL, Lieff S, Howard TA, Eggleston B, Ware RE. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am J Hematol 2008;83:800.
Dewey KW, Grossman H. Cholilithiasis in thalassaemia major. Radiology 1970;96:385-8.
Khandros E, Thom CS, D'Souza J, Weiss MJ. Integrated protein quality-control pathways regulate free α-globin in murine β–thalassemia. Blood 2012;119:5265-75.
Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008;132:27-42.
Botbol V, Scornik OA. Intermediates in the degradation of globin. J Biol Chem 1979;254:11254-57.
Fruitier I, Garreau I, Lacroix, Cupo A, Piot JM. Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides. Hemorphins 1999;447:81-6.
Haverfield EV, McKenzie CA, Forrester T, Bouzekri N, Harding R, Serjeant G, et al. UGT1A1 variation and gallstone formation in sickle cell disease. Blood 2005;105:968-72.
Vasavda N, Menzel S, Kondaveeti S, Maytham E, Awogbade M, Bannister S, et al. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 2007;138:263.
Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol 2001;23:448-51.
Fertrin KY, Melo MB, Assis AM, Saad ST, Costa FF. UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin Genet 2003;64:160-2.
Chaar V, Kéclard L, Diara JP, Leturdu C, Elion J, Krishnamoorthy R, et al. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia. Haematologica 2005;90:188-93.
Mehta S, Lopez ME, Chumpitazi BP, Mazziotti MV, Brandt ML, Fishman DS. Clinical characteristics and risk factors for symptomatic pediatric gallbladder disease. Pediatrics 2012;129:82-8.
Amoako MO, Casella JF, Strouse JJ. High rates of recurrent biliary tract obstruction in children with sickle cell disease. Pediatr Blood Cancer 2013;60:650–2.
Maher MM, Mansour AH. Study of chronic hepatopathy in patients with sickle cell disease. Gastroenterol Res 2009;2:338-43.
Portincasa P, Moschetta A, Berardino M, Di-Ciaula A, Vacca M, Baldassarre G, et al. Impaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults. World J Gastroenterol 2004;10:2383-90.
Walker TM, Hambleton IR, Serjeant GR. Gallstones in sickle cell disease: observations from the jamaican cohort study. J Pediatr 2000;136:80-5.
DK Webb, JS Darby, DT Dunn, SI Terry, GR Serjeant. Gall stones in Jamaican children with homozygous sickle cell disease. Arch Dis Child 1989;64:693.
Sarnaik S, Slovis TL, Corbett DP, Emami A, Whitten CF. Incidence of cholelithiasis in sickle cell anemia using the ultrasonic gray-scale technique. J Pediatr 1980;96:1005-8.
Trevor N Golding, Adeleke Adeyemo, Lewis Kurtz. The Incidence and surgical significance of Cholelithiasis in sickle cell anemia and sickle cell trait. J Natl Med Assoc 1973;65:410-4.
LR Bond, SR Hatty, ME Horn, M Dick, HB Meire, AJ Bellingham. Gall stones in sickle cell disease in the United Kingdom. Br Med J 1987;295:234-6.
Chaar V1, Kéclard L, Etienne-Julan M, Diara JP, Elion J, Krishnamoorthy R, et al. UGT1A1 polymorphism outweight the modest effect of deletional (-3,7 kb) alpha-thalassaemia on chlelithogenesis in sickle cell anaemia. Am J Hematol 2006;81:377-9.
Haidar MZ, Ashebu S, Aduh P, Adekile AD. Influence of alpha thalasaaemia on cholilithiasis in SS patients with elevated Hb-F. Acta Hematol 1998;100:147-50.
Adam S, Jonassaint J, Kruger H, Kail M, Orringer EP, Eckman JR, et al. Surgical and obstetric outcomes in adults with sickle cell disease. Am J Med 2008;121:916-21.
Billa RF, Biwole MS, Juimo AG, Bejanga BI, Blackett K. Gall stone disease in African patients with sickle cell anaemia: a preliminary report from Yaounde, Cameroon. Gut 1991;32:539-41.
Attalla BAI, Karrar ZA, Ibnouf G, Mohamed AO, Abdelwahab O, Nasir EM, et al. Outcome of cholelithiasis in sudanese children with sickle cell anaemia (SCA) after 13 years follow-up. Afr Health Sci 2013;13:154–9.
Al-Mulhim AS, Al-Mulhim AA. Laparoscopic cholecystectomy in 427 adults with sickle cell disease: a single-centerexperience. Surg Endosc 2009;23:1599–602.
Giuseppe Curro, Anna Meo, Daniela Ippolito, Anna Pusiol, Eugenio Cucinotta. Asymptomatic cholelithiasis in children with sickle cell disease early or delayed cholecystectomy? Ann Surg 2007;245:126–9.
Tripathy D, Dash BP, Mohapatra BN, Kar BC. Cholelithiasis in sickle cell disease in India. J Assoc Physicians India 1997;45:287-9.
Pignatti CB, Gamberini MR. Complications of thalassemia major and their treatment. Expert Rev Hematol 2011;4:353-66.
Borgna-Pignatti C, Rigon F, Merlo L, Chakrok R, Micciolo R, Perseu L, et al. Thallassaemia minor, the Gilbert mutation and the risk of gallstones. Haematologica 2003;88:1106-9.
Musallam KM, Taher AT, Rachmilewitz EA. β-Thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med 2012;2:a013482.
Premawardhena A, Fisher CA, Fathiu F, de Silva S, Perera W, Peto TE, et al. Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia. Lancet 2001;357:1945-6.
Kar R, Rao S, Srinivas UM, Mishra P, Pati HP. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India. Hematology 2009;14:164-7.
Cooper RA, Jandl JH. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest 1969;48:736-44.
Del Giudice Em, Perrotta S, Nobili B, Specchia C, D'urzo G, Iolascon A. Coinheritance of gilbert syndrome increases the risk for developing gallstones in patients with hereditary Spherocytosis. Blood 1999;94:2259-62.
AlFadhli S, Al-Jafer H, Hadi M, Al-Mutairi M, Nizam R. The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients. PLoS ONE 2013;8:e77681. doi: 10.1371/journal. pone.0077681.
Al-Salem AH, Nourallah H. Sequential endoscopic/laparascopicmanagment of cholilithiasis and choledocholithiasis in children who have sickle cell disease. L PaediatrSurg 1997;32:1432-35
Rennel MD, Dunne MG, Grossman NJ, Schwartz AD. Cholilithiasis in patients with major sickle hemoglobinopathies. Am J Dis Chil1984;138;66-67.
Marchetti M, Quaglini S, Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analysing the decision in different clinical scenarios. J Inter Med 1998;244:217-26.
Al-Salem AH, Al-Abkari H, Al-Jishi L, Al Jam’a A, Yassin YM. Experience of concomitant splenectomy and cholecystectomy in patients with sickle cell disease. Annals of Saudi Medicine 1997;18:266-68
Krueger HC, Burgert EOJ. Hereditary spherocytosis in 100 children. Mayo ClinProc 1966;41:821.
Alizai NK, Richards EM, Stringer MD. Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Arch Dis Child 2010;95:596-99.
Kar R, Rao S, Srinivas UM, Mishra P, Pati HP. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India. Hematology 2009;14:164-7.
Oliveira MC1, Fernandes RA, Rodrigues CL, Ribeiro DA, Giovanardi MF, Viana MB. Clinical course of 63 children with hereditary spherocytosis: a retrospective study. Rev Bras Hematol Hemoter 2012;34:9-13.
Malone BS, Werlin SL. Cholecystectomy and cholelithiasis in sickle cell anemia. Am J Dis Child 1988;142:799-800.
Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy MM, et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. Preoperative transfusion in sickle cell disease study group. N Engl J Med 1995;333:206-14.
Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, et al. Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. Pediatr Blood Cancer 2008;50:603-6.
Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. Lancet 2013;381:930-8.
Haberkern CM, Neumayr LD, Orringer EP, Earles AN, Robertson SM, Black D, et al. Cholecystectomy in sickle cell anemia patients: perioperative outcome of 364 cases from the national preoperative transfusion study. Blood 1997;89:1533-42.
Al-Salem AH, Qaisruddin S. The significance of biliary sludge in children with sickle cell disease. Pediatr SurgInt 1998;13:14-6.
Gumiero APS, Bellomo-Brandão MA, Costa–Pinto EAL. Gallstones in children with Sickle cell disease followed up at a brazilianhematologycenter. Pediatr Gastroenterol 2008;45:313-8.
Attalla BAI, Karrar ZA, Ibnouf G, Mohamed AO, Abdelwahab O, Nasir EM, et al. Outcome of cholelithiasis in sudanese children with sickle cell anaemia (SCA) after 13 years follow-up. Afr Health Sci 2013;13:154-9.
Curro G, Meo A, Ippolito D, Pusiol A, Cucinotta E. Asymptomatic cholelithiasis in children with sickle cell disease early or delayed Cholecystectomy? Ann Surg 2007;245:126–9.
Hanna T, Shraga A, Enrique F, Hagit M, Tatyana K, Michael S, et al. High incidence of early cholilithiasis detected by ultrasonography in children and young adults with hereditary spherocytosis. J Pediatr Hematol Oncol 2003;25:952-4.
Hendricks-Ferguson V, Nelson MA. Treatment of cholelithiasis I children with sickle cell disease. AORN J 2003;77:1170-82.
Curro G, Iapichino G, Lorenzini C, Palmeri R, Cucinotta E. Laparoscopic cholecystectomy in children with chronic haemolytic anemia. Surg Endosc 2006;20:252–5.
Esposito C, Gonzalez Sabin MA, Corcione F, Sacco R, Esposito G, Settimi A. Results and complications of laparoscopic cholecystectomy in childhood. Surg Endosc 2001;15:890-2.
Tripathy D, Dash BP, Mohapatra BN, Kar BC. Cholelithiasis in sickle cell disease in India. J Assoc Physicians India 1997;45:287-9.
Galanelo R, Barella S, Leoni GB, Cipollina MD, Persue L, Cao A. Cholilithiasis and Gilbert’s syndrome in homozygous beta thalassaemia. Br J Haematol 2011;115:926-8.
Maher MM, Mansour AH. Study of chronic hepatopathy in patients with sickle cell disease. Gastroenterol Res 2009;2:338-43.
Golding TN, Adeyemo A, Kurtz L. The incidence and surgical significance of cholelithiasis in sickle cell anemia and sickle cell trait. J Natl Med Assoc 1973;65:410-4.
Suell MN, Horton TM, Dishop MK, Mahoney DH, Olutoye OO, Mueller BU. Outcomes for children with gallbladder abnormalities and sickle cell disease. J Pediatr 2004;145:617-21.
Origa R, Galanello R, Perseu L, Tavazzi D, Domenica Cappellini M, Terenzani L, et al. Cholelithiasis in thalassemia major. Eur J Haematol 2008;82:22-5.
Agholor CA, Akhigbe AO, Atalabi OM. The prevalence of cholelithiasis in nigerians with sickle cell disease as diagnosed by ultrasound. Br J Med Med Res 2014;4:2866-73.
Durosimi MA, Ogunseyinde AO, Olatunji PO, Esan GJ. Prevalence of cholelithiasisin Nigerians with sickle cell disease. Afr J Med Sci 1989;18:223-7.